Eastman Chemical Company (EMN) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Eastman Chemical Company operates four segments: Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers. The company focuses on an innovation-driven growth model, including investments in molecular recycling technologies.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Sales | $2,290 million | $2,310 million |
| Gross Profit | $567 million | $532 million |
| Gross Margin | 24.8% | 23.0% |
| Net Earnings (Attributable to Eastman) | $182 million | $165 million |
| Diluted EPS | $1.57 | $1.39 |
| Adjusted Net Earnings (Non-GAAP) | $222 million | $190 million |
| Adjusted Diluted EPS (Non-GAAP) | $1.91 | $1.61 |
| Operating Cash Flow | ($167 million) used | ($16 million) used |
| Total Borrowings | $5,021 million | $5,017 million |
| Cash and Equivalents | $418 million | $837 million |
| Net Debt (Non-GAAP) | $4,603 million | $4,180 million |
Material Changes vs. Prior Period
- Revenue: Sales decreased 1% ($20 million) year-over-year, driven by lower volume and unfavorable foreign currency exchange rates, partially offset by higher selling prices.
- Profitability: Earnings Before Interest and Taxes (EBIT) increased 15% to $302 million. Adjusted EBIT (excluding non-core items) rose 14% to $311 million, aided by the absence of start-up costs at the Kingsport methanolysis facility and higher selling prices.
- Segment Performance:
- Additives & Functional Products: Sales up 4% and EBIT up 26% due to higher prices and volume.
- Advanced Materials: Sales down 4% due to lower prices and volume, but EBIT up 12% due to favorable mix and lower SG&A.
- Fibers: Sales down 13% and EBIT down 25% due to customer destocking and a discontinued product.
- Chemical Intermediates: Sales up 4% and EBIT up 19% due to favorable market conditions.
- Cash Flow: Operating cash flow usage increased significantly to $167 million (from $16 million usage in Q1 2024) due to higher working capital requirements and variable compensation payouts.
- Debt Activity: The company issued $250 million in 5.0% notes due 2029 and repaid $450 million in 3.80% notes due 2025. Commercial paper borrowings increased to $285 million.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects 2025 capital expenditures to be approximately $550 million, primarily for the Advanced Materials methanolysis facility and site modernization.
- Dividends: Cash dividends declared were $0.83 per share ($96 million total).
- Stock Repurchases: No shares were repurchased in Q1 2025. $1.1 billion has been repurchased under the 2021 authorization to date.
- Risks: Key risks include global economic conditions, raw material and energy price volatility, foreign currency fluctuations, and potential impacts from tariffs and trade disruptions. The company maintains hedging programs to mitigate these risks.
- Non-Core Items: Q1 2025 included $9 million in asset impairments, restructuring, and other charges, primarily related to the closure of a heat-transfer fluids production line.
Investor Verification Checklist
- Working Capital Trends: Verify the sustainability of the $167 million operating cash outflow and the drivers behind the increase in inventory and receivables.
- Segment Mix: Monitor the continued destocking in the Fibers segment and its impact on future volume.
- Debt Maturity Profile: Review the impact of the new 2029 notes issuance and the repayment of 2025 notes on the overall interest expense and liquidity.
- Non-GAAP Reconciliations: Scrutinize the $32 million interim tax provision adjustment used to calculate Adjusted Net Earnings.
- Capital Project Progress: Track the status and cost overruns of the Kingsport methanolysis facility, which is a major driver of 2025 capex.